Pliant Therapeutics Inc (STU:9PT) Transcripts
Pliant Therapeutics Inc INTEGRIS-PSC Phase 2a Trial Results Call Transcript
Feb 05, 2024
Pliant Therapeutics Inc at JPMorgan Healthcare Conference Transcript
Jan 09, 2024
Pliant Therapeutics Inc at Cantor Fitzgerald Global Healthcare Conference Transcript
Sep 28, 2023
Pliant Therapeutics Inc INTEGRIS-PSC Interim Phase 2a Data Presentation Transcript
Sep 26, 2023
Pliant Therapeutics Inc at Canaccord Genuity Growth Conference Transcript
Aug 10, 2023
Pliant Therapeutics Inc at RBC Capital Markets Global Healthcare Conference Transcript
May 17, 2023
Pliant Therapeutics Inc INTEGRIS-IPF Call Transcript
May 01, 2023
Pliant Therapeutics Inc at Needham Healthcare Conference (Virtual) Transcript
Apr 19, 2023
Pliant Therapeutics Inc at Oppenheimer Healthcare Conference (Virtual) Transcript
Mar 13, 2023
Pliant Therapeutics Inc at Cowen Health Care Conference Transcript
Mar 08, 2023
Pliant Therapeutics Inc at SVB Securities Global Biopharma Conference (Virtual) Transcript
Feb 15, 2023
Pliant Therapeutics Inc Review Data from the 320 mg Group of the INTEGRIS-IPF Phase 2a Trial of Bexotegrast (PLN-74809) in Patients with IPF Call Transcript
Jan 23, 2023
Pliant Therapeutics Inc at Piper Sandler Healthcare Conference Transcript
Nov 30, 2022
Pliant Therapeutics Inc at Evercore ISI HealthCONx Conference (Virtual) Transcript
Nov 29, 2022
Pliant Therapeutics Inc at RBC Capital Markets Biotech Expert Insights: Pulmonary/Lung Disease Mini-Symposium (Virtual) Transcript
Oct 07, 2022
Pliant Therapeutics Inc to Discuss Results from INTEGRIS-IPF Call Transcript
Jul 11, 2022
Pliant Therapeutics Inc Annual Shareholders Meeting Transcript
Jun 16, 2022
Pliant Therapeutics Inc at RBC Capital Markets Global Healthcare Conference Transcript
May 18, 2022
Pliant Therapeutics Inc at Needham Healthcare Conference (Virtual) Transcript
Apr 12, 2022